Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: The CLASSIC-I Trial

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2005.11.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Infliximab (Anti–Tumor Necrosis Factor Α Antibody)

Archives of Dermatology
2001English

A Cell-Killing Monoclonal Antibody (Anti-Fas) to a Cell Surface Antigen Co-Downregulated With the Receptor of Tumor Necrosis Factor

Journal of Experimental Medicine
MedicineAllergyImmunology
1989English

Golimumab: A Novel Anti-Tumor Necrosis Factor

Biologics in Therapy
2013English

Recognition of Human Tumor Necrosis Factor Α (TNF-α) by Therapeutic Antibody Fragment

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Selective Improvement of Tumor Necrosis Factor Capture in a Cytokine Hemoadsorption Device Using Immobilized Anti-Tumor Necrosis Factor

Journal of Biomedical Materials Research - Part B Applied Biomaterials
Biomedical EngineeringBiomaterials
2010English

Tumor Necrosis Factor Alpha in Inflammatory Bowel Disease.

Gut
Gastroenterology
1994English

Immunogenicity Negatively Influences the Outcome of Adalimumab Treatment in Crohn’s Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2008English

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

Levels of Intestinal Inflammation and Fibrosis in Resection Specimens After Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients With Crohn’s Disease: A Comparative Pilot Study

Surgery Research and Practice
Nuclear MedicineRadiologyImaging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy